Corteva, Inc.
For the period ended Dec 31, 2025. Filed Feb 12, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 12, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Income Taxes
NOTE 3 -INCOME TAXES
Refer to page F-23 of the Corteva, Inc. Consolidated Financial Statements for discussion of tax items that do not differ between Corteva, Inc. and EIDP. Since the reconciliation to the U.S. statutory rate for the year ended December 31, 2025 is the same for both Corteva, Inc. and EIDP, such information is omitted from the table below.
| Geographic Allocation of Income (Loss) and Provision for (Benefit from) Income Taxes | For the Year Ended December 31, | ||
|---|---|---|---|
| (In millions) | 2025 | 2024 | 2023 |
| Income (loss) from continuing operations before income taxes | |||
| Domestic | $325 | $363 | $(434) |
| Foreign | 1,363 | 951 | 1,507 |
| Income (loss) from continuing operations before income taxes | $1,688 | $1,314 | $1,073 |
| Current tax expense (benefit) | |||
| Federal | $87 | $292 | $138 |
| State and local | 26 | 47 | 40 |
| Foreign | 412 | 447 | 407 |
| Total current tax expense (benefit) | $525 | $786 | $585 |
| Deferred tax expense (benefit) | |||
| Federal | $(139) | $(300) | $(326) |
| State and local | (24) | (28) | (50) |
| Foreign | 122 | (37) | (62) |
| Total deferred tax expense (benefit) | $(41) | $(365) | $(438) |
| Provision for (benefit from) income taxes on continuing operations | 484 | 421 | 147 |
| Net income (loss) from continuing operations | $1,204 | $893 | $926 |
| Reconciliation to U.S. Statutory Rate | For the Year Ended December 31, | |
|---|---|---|
| 2024 | 2023 | |
| Statutory U.S. federal income tax rate | 21.0% | 21.0% |
| Effective tax rates on international operations - net 1 | 4.6 | (1.9) |
| Acquisitions, divestitures and ownership restructuring activities 2 | (1.1) | 3.6 |
| U.S. research and development credit | (4.5) | (6.0) |
| Exchange gains/losses 3 | 1.7 | 2.0 |
| State and local income taxes - net | 1.3 | 0.9 |
| Impact of Swiss Tax Changes 4 | — | (8.0) |
| Excess tax benefits/deficiencies from stock compensation | (0.2) | (0.6) |
| Tax settlements and expiration of statute of limitations | (1.6) | (0.4) |
| Impact of Brazil valuation allowance 6 | 9.1 | — |
| Repatriation of foreign earnings 5 | 1.7 | 2.9 |
| Other – net | — | 0.2 |
| Effective tax rate | 32.0% | 13.7% |
Includes the effects of local and U.S. taxes related to earnings of non-U.S. subsidiaries, changes in the amount of unrecognized tax benefits associated with these earnings, losses at non-U.S. subsidiaries without local tax benefits due to valuation allowances, and other permanent differences between tax and U.S. GAAP results.
Includes a tax charge of $46 million for the year ended December 31, 2023 associated with intellectual property realignment.
Principally reflects the impact of foreign exchange gains and losses on net monetary assets for which no corresponding tax impact is realized. Further information about the company's foreign currency hedging program is included in Note 6 - Supplementary Information, and Note 19 - Financial Instruments, under the heading Foreign Currency Risk.
Includes net tax benefits of $(62) million and $(24) million for the year ended December 31, 2023, related to changes in deferred taxes and a tax currency change, respectively.
Includes the effect of withholding tax on distribution of foreign earnings to the U.S., net of U.S. foreign tax credits.
For the year ended December 31, 2024, a charge of $120 million was recorded to establish a valuation allowance against the net deferred tax asset position of
a legal entity in Brazil (Seed business).
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.